How we use cookies on bronchiectasis-rti.org.
This Cookies Policy explains what cookies are, how we use them, and how you can manage them on this website. By using the website, you agree to the use of cookies as outlined here.
Cookies are small text files stored on your device (computer, tablet or smartphone) when you visit a website. They are widely used to make websites work more efficiently, and to provide information to the website owners.
Necessary for the website to function. They cannot be switched off in our systems.
Collect information about how you use the website, such as which pages you visit most often.
Enable enhanced functionality and personalisation.
Track online activity to help deliver relevant advertisements.
WeMeet Web® is an integral part of the websites we build and uses technical and essential cookies. It is also used to help prevent cyber attacks.
We may allow third-party service providers to place cookies on your device. Those providers may use the information collected to deliver advertisements relevant to your interests.
You can manage or delete cookies in your browser settings. Most browsers allow you to view stored cookies, delete all or selected cookies, block third-party cookies, block all cookies, or receive a notification when a website tries to set a cookie. Disabling cookies may affect your experience; some features may not function properly.
We may update this Cookies Policy from time to time. Changes will be posted on this page and, where appropriate, notified by email.
Questions about this Cookies Policy: privacy@lenagroup.net · +377 97 97 35 55.
Michal Shteinberg is heading the bronchiectasis and adult CF service in the Pulmonology institute and CF center, Carmel medical center, Haifa, Israel. She is a Clinical Assistant Professor in the Faculty of medicine at the Technion, Israel Institute of Technology. Her main research interests are bronchiectasis and its overlap with other airway diseases, and adult CF.
Head of the Pulmonology Service at Hospital Clínic de Barcelona and accredited researcher in the IDIBAPS group Inflammation and Repair in Respiratory Diseases. His work focuses on airway infection, inflammation and bronchiectasis, including frequent-exacerbator phenotypes in the EMBARC registry.
He coordinates educational programmes on bronchiectasis at Hospital Clínic and publishes widely on mucins, inhaled therapies and treatable traits in chronic airway disease.
Natalie Lorent works as a consultant in Respiratory Medicine/Clinical Infectiology at the University Hospital Leuven where since 2015 she coordinates the care for adults with respiratory infections, bronchiectasis (CF and non-CF) and primary ciliary dyskinesia. She is involved in clinical and translational research in bronchiectasis and mycobacterial infections.
She is founder and president of the national NTM Consilium, a clinical advisory board and basis of a national registry; she chairs the European NTM research network (NTMnet) and the Belgian MDRTB expert group. She has been involved in EMBARC since the start. Natalie is also assistant professor at KU Leuven.
Felix C. Ringshausen is a board-certified physician for respiratory medicine and infectious diseases and head of the Adult Bronchiectasis and Cystic Fibrosis Service at the Hannover Medical School, Germany. In addition, he is principal investigator of the German Center for Lung Research (DZL).
His research interests are focused on European multidisciplinary networks and multicenter initiatives in order to promote clinically orientated research and improve patient care in the field of rare, neglected and under-researched aspects of respiratory infections like bronchiectasis, nontuberculous mycobacteria, respiratory viruses and adult cystic fibrosis.
Professor of Respiratory Medicine, Humanitas University, Milan, Italy. Consultant, Respiratory Unit and Adult Cystic Fibrosis Center, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan.
Co-chair of the European Bronchiectasis Network (EMBARC). Chair of IRIDE, the Italian Registry of adult bronchiectasis. Chair of the Italian Registry on Non-Tuberculous Mycobacteria (IRENE).
Professor Michael Loebinger is Professor of Practice at Imperial College London and Director of the Lung Division and Deputy Medical Director at Royal Brompton Hospital. He co-chaired the British Thoracic Society bronchiectasis guidelines and co-wrote the BTS Non-Tuberculous Mycobacteria and European Respiratory Society bronchiectasis guidelines.
He is a founding member of the UK and European clinical and research bronchiectasis and NTM networks and has authored over 200 publications. He has helped design and lead multiple global clinical trials in bronchiectasis and NTM and was chief investigator for the first mRNA trials in primary ciliary dyskinesia.
Charles Haworth is a Respiratory Consultant working within the Cambridge Centre for Lung Infection at Royal Papworth Hospital where he specialises in treating adults with bronchiectasis, non-tuberculous mycobacterial (NTM) infections and cystic fibrosis.
He co-authored the British Thoracic Society Bronchiectasis clinical guidelines published in 2017 and the European Respiratory Society Bronchiectasis clinical guidelines published in 2019.
He was also senior author of the International Cystic Fibrosis NTM guidelines published in 2015 and first author of the British Thoracic Society NTM guidelines published in 2017.
From 2018 to 2021, he was a founding and executive committee member of the UK Cystic Fibrosis Medical Association.
In June 2024 he was invited to join the Board of the European Cystic Fibrosis Society.
Rhodes Chair of Experimental Therapeutics and Clinical Pharmacology, University of Oxford.
Chief Editor of the European Respiratory Journal.
Chair of the European Bronchiectasis Network (EMBARC).
Chair of the Standards of Care Committee of the British Thoracic Society.
